Phosphodiesterases in the CNS: targets for drug development

Many phosphodiesterases are expressed in the CNS, and are attractive targets for the treatment of psychiatric and neurodegenerative disorders. Menniti et al. review current understanding of the phosphodiesterase gene family in the CNS and the implications of targeting these enzymes in this therapeutic area.